Akèy › Kolit Ulseratif › Arizona
Etid klinik pou Kolit Ulseratif nan Arizona
19 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan Arizona.
Vil nan Arizona
Tèks ofisyèl etid la (Anglè)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Elite Clinical Studies /ID# 280477, Phoenix
- Gi Alliance - Arizona Digestive Health - Sun City /ID# 284084, Sun City
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- AZ Gastro Care, Chandler
- Spectrum Research Institute LLC, Gilbert
- GI Alliance- Sun City, Sun City
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Phoenix Children's Hospital /ID# 273015, Phoenix
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- AZ Gastro Care - Chandler, Chandler
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Scottsdale
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-022, Sun City
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- AZ Gastro Care, Chandler
- Research Solutions of Arizona, Litchfield Park
- Mayo Clinic, Scottsdale
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Mayo Clinic in Arizona - Scottsdale, Scottsdale
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Valleywise Health Medical Center, Phoenix
- One of a Kind Clinical Research Center, Scottsdale
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- GI Alliance Sun City, Sun City
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Del Sol Research Management, LLC - Site Number: 8400012, Tucson
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07185009A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- One of a Kind Clinical Research Center, Scottsdale
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 21, 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Onyx Clinical Research - Site Number: 8400021, Peoria
- One of a Kind Clinical Research Center LLC - Site Number: 8400061, Scottsdale
- Scottsdale Clinical Trials - Site Number: 8400145, Scottsdale
- ak 1 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Arizona, Scottsdale
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Phoenix Children's Hospital, Phoenix
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Aug 3, 2026 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Reddy GI Associates, Mesa
Ap rekriteEtid obsèvasyon
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Phoenix Childrens Hospital, Phoenix
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Jun 22, 2026 · NCT06405087A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Phoenix Childrens Hospital - Thomas Rd - PIN, Phoenix
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Scottsdale
- Mirador Therapeutics Selected Site, Sun City
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.